These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 28352268)

  • 21. Interferon-gamma receptor-deficient mice exhibit impaired gut mucosal immune responses but intact oral tolerance.
    Kjerrulf M; Grdic D; Ekman L; Schön K; Vajdy M; Lycke NY
    Immunology; 1997 Sep; 92(1):60-8. PubMed ID: 9370925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections.
    Lin JD; Feng N; Sen A; Balan M; Tseng HC; McElrath C; Smirnov SV; Peng J; Yasukawa LL; Durbin RK; Durbin JE; Greenberg HB; Kotenko SV
    PLoS Pathog; 2016 Apr; 12(4):e1005600. PubMed ID: 27128797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Protective Role of Type I Interferons in the Gastrointestinal Tract.
    Kotredes KP; Thomas B; Gamero AM
    Front Immunol; 2017; 8():410. PubMed ID: 28428788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.
    Yu D; Zhao M; Dong L; Zhao L; Zou M; Sun H; Zhang M; Liu H; Zou Z
    Drug Des Devel Ther; 2016; 10():163-82. PubMed ID: 26792983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased expression of type I (IFN-β) and type III (IFN-λ) interferons and interferon-stimulated genes in patients with chronic rhinosinusitis with and without nasal polyps.
    Hwang JW; Lee KJ; Choi IH; Han HM; Kim TH; Lee SH
    J Allergy Clin Immunol; 2019 Dec; 144(6):1551-1565.e2. PubMed ID: 31449915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.
    Awad WA; Hess C; Hess M
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine gammaherpesvirus targets type I IFN receptor but not type III IFN receptor early in infection.
    Lopušná K; Benkóczka T; Lupták J; Matúšková R; Lukáčiková Ľ; Ovečková I; Režuchová I
    Cytokine; 2016 Jul; 83():158-170. PubMed ID: 27152708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon Lambda Genetics and Biology in Regulation of Viral Control.
    Hemann EA; Gale M; Savan R
    Front Immunol; 2017; 8():1707. PubMed ID: 29270173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance.
    Kulkarni N; Pathak M; Lal G
    J Leukoc Biol; 2017 Feb; 101(2):377-394. PubMed ID: 27899415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology.
    Stange J; Hepworth MR; Rausch S; Zajic L; Kühl AA; Uyttenhove C; Renauld JC; Hartmann S; Lucius R
    J Immunol; 2012 Mar; 188(5):2410-8. PubMed ID: 22266282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis.
    He L; Liu T; Shi Y; Tian F; Hu H; Deb DK; Chen Y; Bissonnette M; Li YC
    Endocrinology; 2018 Feb; 159(2):967-979. PubMed ID: 29228157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.
    Galani IE; Triantafyllia V; Eleminiadou EE; Koltsida O; Stavropoulos A; Manioudaki M; Thanos D; Doyle SE; Kotenko SV; Thanopoulou K; Andreakos E
    Immunity; 2017 May; 46(5):875-890.e6. PubMed ID: 28514692
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal barrier function.
    Baumgart DC; Dignass AU
    Curr Opin Clin Nutr Metab Care; 2002 Nov; 5(6):685-94. PubMed ID: 12394645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon Regulatory Factor 1 Protects against Chikungunya Virus-Induced Immunopathology by Restricting Infection in Muscle Cells.
    Nair S; Poddar S; Shimak RM; Diamond MS
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sources of Type I Interferons in Infectious Immunity: Plasmacytoid Dendritic Cells Not Always in the Driver's Seat.
    Ali S; Mann-Nüttel R; Schulze A; Richter L; Alferink J; Scheu S
    Front Immunol; 2019; 10():778. PubMed ID: 31031767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Type III Interferon (IFN-λ) in Chinese Goose: Gene Structure, Age-Dependent Expression Profile, and Antiviral Immune Characteristics In Vivo and In Vitro.
    Zhou Q; Zhang W; Chen S; Wang A; Sun L; Wang M; Jia R; Zhu D; Liu M; Sun K; Yang Q; Wu Y; Chen X; Cheng A
    J Interferon Cytokine Res; 2017 Jun; 37(6):269-277. PubMed ID: 28388308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.